{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T09:26:11Z","timestamp":1743067571507,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":17,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493978649"},{"type":"electronic","value":"9781493978656"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-1-4939-7865-6_7","type":"book-chapter","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T17:03:16Z","timestamp":1527181396000},"page":"97-115","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["RNA-Sequencing from Low-Input Material in Multiple Myeloma for Application in Clinical Routine"],"prefix":"10.1007","author":[{"given":"Anja","family":"Seckinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomi","family":"B\u00e4hr-Ivacevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Benes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Hose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,25]]},"reference":[{"issue":"34","key":"7_CR1","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1200\/JCO.2012.48.4923","volume":"31","author":"K Neben","year":"2013","unstructured":"Neben K, Jauch A, Hielscher T, Hillengass J, Lehners N, Seckinger A, Granzow M, Raab MS, Ho AD, Goldschmidt H, Hose D (2013) Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load. J Clin Oncol 31(34):4325\u20134332","journal-title":"J Clin Oncol"},{"unstructured":"Seckinger A, Hose D (2015) Dissecting the Clonal Architecture of Multiple Myeloma. Paper presented at the 20th Congress of the European Hematology Association, Vienna, Austria","key":"7_CR2"},{"issue":"1","key":"7_CR3","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1182\/blood-2008-10-184226","volume":"114","author":"D Hose","year":"2009","unstructured":"Hose D, Moreaux J, Meissner T, Seckinger A, Goldschmidt H, Benner A, Mahtouk K, Hillengass J, R\u00e8me T, Vos JD, Hundemer M, Condomines M, Bertsch U, Rossi J-F, Jauch A, Klein B, M\u00f6hler T (2009) Induction of angiogenesis by normal and malignant plasma cells. Blood 114(1):128\u2013143","journal-title":"Blood"},{"key":"7_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3324\/haematol.2010.030296","volume":"96","author":"D Hose","year":"2011","unstructured":"Hose D, Reme T, Hielscher T, Moreaux J, Meissner T, Seckinger A, Benner A, Shaughnessy JD, Barlogie B, Zhou Y, Hillengass J, Bertsch U, Neben K, Mohler T, Rossi JF, Jauch A, Klein B, Goldschmidt H (2011) Proliferation is a central independent prognostic factor and target for personalized and risk adapted treatment in multiple myeloma. Haematologica 96:87\u201395","journal-title":"Haematologica"},{"issue":"18","key":"7_CR5","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.1182\/blood-2008-09-178350","volume":"113","author":"D Hose","year":"2009","unstructured":"Hose D, R\u00e8me T, Meissner T, Moreaux J, Seckinger A, Lewis J, Benes V, Benner A, Hundemer M, Hielscher T, Shaughnessy JD, Barlogie B, Neben K, Kr\u00e4mer A, Hillengass J, Bertsch U, Jauch A, Vos JD, Rossi J-F, M\u00f6hler T, Blake J, Zimmermann J, Klein B, Goldschmidt H (2009) Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma. Blood 113(18):4331\u20134340","journal-title":"Blood"},{"issue":"5","key":"7_CR6","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1182\/blood-2012-03-415588","volume":"120","author":"A Seckinger","year":"2012","unstructured":"Seckinger A, Mei\u00dfner T, Moreaux J, Depeweg D, Hillengass J, Hose K, Reme T, Rosen-Wolff A, Jauch A, Schnettler R, Ewerbeck V, Goldschmidt H, Klein B, Hose D (2012) Clinical and prognostic role of annexin A2 in multiple myeloma. Blood 120(5):1087\u20131094. \nhttps:\/\/doi.org\/10.1182\/blood-2012-03-415588","journal-title":"Blood"},{"issue":"44","key":"7_CR7","doi-asserted-by":"publisher","first-page":"3866","DOI":"10.1038\/onc.2009.257","volume":"28","author":"A Seckinger","year":"2009","unstructured":"Seckinger A, Meissner T, Moreaux J, Goldschmidt H, Fuhler GM, Benner A, Hundemer M, R\u00e8me T, Shaughnessy JD, Barlogie B, Bertsch U, Hillengass J, Ho AD, Pantesco V, Jauch A, Vos JD, Rossi JF, M\u00f6hler T, Klein B, Hose D (2009) Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis. Oncogene 28(44):3866\u20133879","journal-title":"Oncogene"},{"issue":"8","key":"7_CR8","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1182\/blood-2006-08-040410","volume":"109","author":"H Avet-Loiseau","year":"2007","unstructured":"Avet-Loiseau H, Attal M, Moreau P, Charbonnel C, Garban F, Hulin C, Leyvraz S, Michallet M, Yakoub-Agha I, Garderet L, Marit G, Michaux L, Voillat L, Renaud M, Grosbois B, Guillerm G, Benboubker L, Monconduit M, Thieblemont C, Casassus P, Caillot D, Stoppa A-M, Sotto J-J, Wetterwald M, Dumontet C, Fuzibet J-G, Azais I, Dorvaux V, Zandecki M, Bataille R, Minvielle S, Harousseau J-L, Facon T, Mathiot C (2007) Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe francophone du Myelome. Blood 109(8):3489\u20133495","journal-title":"Blood"},{"issue":"23","key":"7_CR9","doi-asserted-by":"publisher","first-page":"7240","DOI":"10.1158\/1078-0432.CCR-11-1628","volume":"17","author":"T Mei\u00dfner","year":"2011","unstructured":"Mei\u00dfner T, Seckinger A, R\u00e8me T, Hielscher T, M\u00f6hler T, Neben K, Goldschmidt H, Klein B, Hose D (2011) Gene expression profiling in multiple myeloma--reporting of entities, risk, and targets in clinical routine. Clin Cancer Res 17(23):7240\u20137247","journal-title":"Clin Cancer Res"},{"issue":"6","key":"7_CR10","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1182\/blood-2006-07-038430","volume":"109","author":"JD Shaughnessy","year":"2007","unstructured":"Shaughnessy JD, Zhan F, Burington BE, Huang Y, Colla S, Hanamura I, Stewart JP, Kordsmeier B, Randolph C, Williams DR, Xiao Y, Xu H, Epstein J, Anaissie E, Krishna SG, Cottler-Fox M, Hollmig K, Mohiuddin A, Pineda-Roman M, Tricot G, van Rhee F, Sawyer J, Alsayed Y, Walker R, Zangari M, Crowley J, Barlogie B (2007) A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1. Blood 109(6):2276\u20132284","journal-title":"Blood"},{"issue":"9","key":"7_CR11","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/bioinformatics\/btt124","volume":"29","author":"T Reme","year":"2013","unstructured":"Reme T, Hose D, Theillet C, Klein B (2013) Modeling risk stratification in human cancer. Bioinformatics 29(9):1149\u20131157. \nhttps:\/\/doi.org\/10.1093\/bioinformatics\/btt124","journal-title":"Bioinformatics"},{"issue":"29","key":"7_CR12","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1200\/JCO.2007.13.8545","volume":"26","author":"O Decaux","year":"2008","unstructured":"Decaux O, Lod\u00e9 L, Magrangeas F, Charbonnel C, Gouraud W, J\u00e9z\u00e9quel P, Attal M, Harousseau J-L, Moreau P, Bataille R, Campion L, Avet-Loiseau H, Minvielle S, du My\u00e9lome IF (2008) Prediction of survival in multiple myeloma based on gene expression profiles reveals cell cycle and chromosomal instability signatures in high-risk patients and hyperdiploid signatures in low-risk patients: a study of the Intergroupe francophone du My\u00e9lome. J Clin Oncol 26(29):4798\u20134805","journal-title":"J Clin Oncol"},{"issue":"1","key":"7_CR13","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1182\/blood-2005-01-0034","volume":"106","author":"PL Bergsagel","year":"2005","unstructured":"Bergsagel PL, Kuehl WM, Zhan F, Sawyer J, Barlogie B, Shaughnessy J (2005) Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. Blood 106(1):296\u2013303","journal-title":"Blood"},{"issue":"6","key":"7_CR14","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1182\/blood-2005-11-013458","volume":"108","author":"F Zhan","year":"2006","unstructured":"Zhan F, Huang Y, Colla S, Stewart JP, Hanamura I, Gupta S, Epstein J, Yaccoby S, Sawyer J, Burington B, Anaissie E, Hollmig K, Pineda-Roman M, Tricot G, van Rhee F, Walker R, Zangari M, Crowley J, Barlogie B, Shaughnessy JD (2006) The molecular classification of multiple myeloma. Blood 108(6):2020\u20132028","journal-title":"Blood"},{"issue":"3","key":"7_CR15","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ccell.2017.02.002","volume":"31","author":"A Seckinger","year":"2017","unstructured":"Seckinger A, Delgado JA, Moser S, Moreno L, Neuber B, Grab A, Lipp S, Merino J, Prosper F, Emde M, Delon C, Latzko M, Gianotti R, L\u00fcoend R, Murr R, Hosse RJ, Harnisch LJ, Bacac M, Fauti T, Klein C, Zabaleta A, Hillengass J, Cavalcanti-Adam EA, Ho AD, Hundemer M, San Miguel JF, Strein K, Uma\u00f1a P, Hose D, Paiva B, Vu MD (2017) Target expression, generation, preclinical activity, and pharmacokinetics of the BCMA-T cell bispecific antibody EM801 for multiple myeloma treatment. Cancer Cell 31(3):396\u2013410","journal-title":"Cancer Cell"},{"issue":"8","key":"7_CR16","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1158\/2159-8290.CD-13-0014","volume":"3","author":"M Andrulis","year":"2013","unstructured":"Andrulis M, Lehners N, Capper D, Penzel R, Heining C, Huellein J, Zenz T, von Deimling A, Schirmacher P, Ho AD, Goldschmidt H, Neben K, Raab MS (2013) Targeting the BRAF V600E mutation in multiple myeloma. Cancer Discov 3(8):862\u2013869. \nhttps:\/\/doi.org\/10.1158\/2159-8290.CD-13-0014","journal-title":"Cancer Discov"},{"issue":"36","key":"7_CR17","doi-asserted-by":"publisher","first-page":"39165","DOI":"10.18632\/oncotarget.5381","volume":"6","author":"A Seckinger","year":"2015","unstructured":"Seckinger A, Meissner T, Moreaux J, Benes V, Hillengass J, Castoldi M, Zimmermann J, Ho AD, Jauch A, Goldschmidt H, Klein B, Hose D (2015) miRNAs in multiple myeloma\u2014a survival relevant complex regulator of gene expression. Oncotarget 6(36):39165\u201339183. \nhttps:\/\/doi.org\/10.18632\/oncotarget.5381","journal-title":"Oncotarget"}],"container-title":["Methods in Molecular Biology","Multiple Myeloma"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-7865-6_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T14:04:44Z","timestamp":1596636284000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-7865-6_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9781493978649","9781493978656"],"references-count":17,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-7865-6_7","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2018]]},"assertion":[{"value":"25 May 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}